Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00085423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: sargramostim
DRUG: cyclophosphamide
DRUG: fludarabine phosphate

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]